See every side of every news story
Published loading...Updated

Neural shares commence trading on Frankfurt Stock Exchange - BioTuesdays

Summary by biotuesdays.com
Neural Therapeutics (CSE:NURL) announced that shares of the company have commenced trading on the Frankfurt Stock Exchange under symbol “M6B”. The company is developing therapeutics to address mental illnesses related to substance use disorders, including alcohol and opioid dependence. In a statement, Ian Campbell, CEO of Neural, commented, “Listing our shares on a Frankfurt Stock Exchange will provide us with access to an expanded international…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

biotuesdays.com broke the news in on Monday, March 31, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.